SciVision Biotech Inc
TWSE:1786
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
71.9
128
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| TW |
|
SciVision Biotech Inc
TWSE:1786
|
5.9B TWD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.7T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
30.7B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
35.8B USD |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
120.3B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.9B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP |
Loading...
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.8T KRW |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.2B CHF |
Loading...
|
Market Distribution
| Min | -21 347.1% |
| 30th Percentile | 0.7% |
| Median | 5% |
| 70th Percentile | 11.5% |
| Max | 698% |
Other Profitability Ratios
SciVision Biotech Inc
Glance View
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for SciVision Biotech Inc is 22.5%, which is below its 3-year median of 27.1%.
Over the last 3 years, SciVision Biotech Inc’s Operating Margin has decreased from 22.9% to 22.5%. During this period, it reached a low of 22.5% on Oct 30, 2025 and a high of 30% on Sep 30, 2024.